Benjamin Pollock, DO
Neurology · Mechanicsburg, PANPI 1023351285
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $629 of the $729 with a category attached, or 86.3%. Every reported general payment came from a single manufacturer, Teva Pharmaceuticals USA, Inc.. Reporting peaked in 2022 at $392 and has fallen 55.7% since, to $173 in 2023. That places this record below the midpoint for neurology clinicians in PA, where the typical reported total is $778.
Across 61 payments — averaging $11.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$729
What the payments were for
- Food & beverage$62986%
- Education$10014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 61 | $729 |
How this compares
$729 in reported general payments places this provider in the 45th percentile of 941 neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 48 | $34,533 |
| Emgality PenGalcanezumab-Gnlm | 42 | $29,786 |
| Nurtec OdtRimegepant Sulfate | 22 | $27,588 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 34 | $23,072 |
| VimpatLacosamide | 12 | $13,712 |
| Lacosamide | 26 | $5,871 |
| Sumatriptan Succinate | 30 | $4,637 |
| Azathioprine | 21 | $3,279 |
| Pyridostigmine Bromide | 33 | $3,212 |
| Gabapentin | 143 | $2,022 |
| Phenobarbital | 30 | $1,941 |
| Levetiracetam | 32 | $1,592 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 65 | $1,405 |
| Primidone | 23 | $1,221 |
| Zonisamide | 20 | $1,117 |
Paid to pharmacies, not to this prescriber.
Other neurology in Mechanicsburg
- William JensMechanicsburg$184K
- Daniel KremensPhiladelphia$1.8M
- Thomas LeistPhiladelphia$1.4M
- Jill Giordano FarmerPhiladelphia$1.2M
- Ravi DukkipatiYork$936K
- Brad KleinAbington$927K
- Stephanie Nahas-GeigerPhiladelphia$786K
- John KhouryAbington$686K
- Amit Bar-OrPhiladelphia$596K
- Behrang SaminejadAllentown$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.